N
VTGN icon

Nuveen’s VistaGen Therapeutics VTGN Stock Holding History

Nuveen’s Portfolio VTGN Stock Details VTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-18,587
Closed -$597K – 3142
2022
Q4 		$597K Sell
18,587
-1,136
-6% -$4.28K ﹤0.01% 2836
2022
Q3 		$633K Sell
19,723
-66
-0.3% -$654 ﹤0.01% 2901
2022
Q2 		$523K Sell
19,789
-521
-3% -$18.4K ﹤0.01% 3005
2022
Q1 		$719K Buy
20,310
+275
+1% +$12K ﹤0.01% 2917
2021
Q4 		$1.05M Sell
20,035
-1,944
-9% -$127K ﹤0.01% 2848
2021
Q3 		$1.97M Sell
21,979
-900
-4% -$78.2K ﹤0.01% 2676
2021
Q2 		$2.16M Buy
+22,879
New +$1.7M ﹤0.01% 2673

Other funds holding VTGN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.6B AUM 18.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return